Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Hermann Josef Vormoor.

Newcastle AuthorsTitleYearFull text
Liz Matheson
Huw Thomas
Marian Case
Dr Helen Blair
Rosanna Jackson
et al.
Glucocorticoids and selumetinib are highly synergistic in RAS pathway mutated childhood acute lymphoblastic leukemia through upregulation of BIM2019
Professor Olaf Heidenreich
Professor Hermann Josef Vormoor
Epidemiology and biology of relapse after stem cell transplantation2018
Professor Olaf Heidenreich
Professor Hermann Josef Vormoor
The MLL recombinome of acute leukemias in 20172018
Dr Britta Vormoor
Professor Gareth Veal
Melanie Griffin
Professor Julie Irving
Lynne Minto
et al.
A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia2017
Dr Alex Elder
Dr Simon Bomken
Dr Ian Wilson
Dr Helen Blair
Dr Simon Cockell
et al.
Abundant and equipotent founder cells establish and maintain acute lymphoblastic leukaemia2017
Professor Andrew Pearson
Dr Pamela Kearns
Professor Hermann Josef Vormoor
Early phase clinical trials of anticancer agents in children and adolescents - an ITCC perspective2017
Professor Andrew Pearson
Professor Hermann Josef Vormoor
From class waivers to precision medicine in paediatric oncology2017
Professor Hermann Josef Vormoor
Geoff Bell
"Including" Patients in the North. Development of an Early Phase Trials Network in the North of Britain2016
Judith Weiland
Dr Deepali Pal
Marian Case
Professor Julie Irving
Dr Frida Ponthan
et al.
BCP-ALL blasts are not dependent on CD19 expression for leukaemic maintenance2016
Dr Deepali Pal
Professor Olaf Heidenreich
Professor Hermann Josef Vormoor
Dormancy Stems the Tide of Chemotherapy2016
Dr Lynsey McKenzie
Dr Sirintra Nakjang
Dr Helen Blair
Professor Hermann Josef Vormoor
Professor Olaf Heidenreich
et al.
Identification of CCND2 As a RUNX1/ETO Target Required for Leukaemic Propagation2016
Dr Deepali Pal
Dr Helen Blair
Dr Alex Elder
Katie Dormon
Dr Kate Rennie
et al.
Long-term in vitro maintenance of clonal abundance and leukaemia-initiating potential in acute lymphoblastic leukaemia2016
Dr Alex Elder
Dr Klaus Rehe
Dr Simon Bomken
Dr Paul Sinclair
Katie Dormon
et al.
The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts.2016
Katie Dormon
Elda Latif
Dr Matthew Bashton
Dr Deepali Pal
Dr Helen Blair
et al.
A Whole Genome In Vivo Crispr Screen in Primary ALL Predicts Leukaemic Relapse2015
Judith Weiland
Dr Alex Elder
Dr Victoria Forster
Professor Olaf Heidenreich
Professor Hermann Josef Vormoor
et al.
CD19: A multifunctional immunological target molecule and its implications for Blineage acute lymphoblastic leukemia2015
Dr Klaus Rehe
Dr Simon Bomken
Dr Paul Sinclair
Dr Lisa Russell
Professor Olaf Heidenreich
et al.
Childhood pre-B acute lymphoblastic leukaemia cells capable of central nervous system engraftment are common, heterogeneous and transit the blood-cerebrospinal fluid barrier2015
Dr Alex Elder
Dr Helen Blair
Katie Dormon
Dr Simon Bomken
Dr Simon Cockell
et al.
High Abundance of Acute Lymphoblastic Leukaemia Founder Clones Does Not Translate to Functional Heterogeneity2015
Dr Natalie Bell
Dr Helen Blair
Lisa Price
Dr Katrina Wood
Professor Hermann Josef Vormoor
et al.
Patient-derived xenograft and in vivo bioluminescent modelling of B-cell NHL2015
Professor Julie Irving
Elizabeth Matheson
Helen Blair
Marian Case
Isabella Swidenbank
et al.
Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. Blood. 2014;124(23):3420-34302015
Dr Frida Ponthan
Dr Simon Bomken
Dr Deepali Pal
Dr Alex Elder
Hesta McNeill
et al.
A Genome-Wide RNAi Screen to Identify Novel Genes Involved in Clonal Maintenance of ALL2014
Dr Britta Vormoor
Henrike Knizia
Michael Batey
Dr Ian Wilson
Dr Petra Dildey
et al.
Development of a Preclinical Orthotopic Xenograft Model of Ewing Sarcoma and Other Human Malignant Bone Disease Using Advanced In Vivo Imaging2014
Dr Natalie Bell
Dr Helen Blair
Professor Hermann Josef Vormoor
Dr Christopher Bacon
Dr Vikki Rand
et al.
Development of in Vivo Models of Paediatric Burkitt Lymphoma Allowing Therapeutic Target Analysis and Drug Testing2014
Dr Alex Elder
Dr Simon Bomken
Dr Helen Blair
Professor Hermann Josef Vormoor
Professor Olaf Heidenreich
et al.
Differential expression of miR-17~92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia2014
Dr Simon Bomken
Dr Helen Blair
Professor Hermann Josef Vormoor
Professor Olaf Heidenreich
Preclinical modelling of childhood acute lymphoblastic leukaemia2014
Professor Julie Irving
Elizabeth Matheson
Dr Helen Blair
Marian Case
Isabella Swidenbank
et al.
Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition2014
Dr Klaus Rehe
Kerrie Wilson
Dr Simon Bomken
Dr Daniel Williamson
Professor Julie Irving
et al.
Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populations2013
Dr Simon Bomken
Dr Lars Buechler
Dr Klaus Rehe
Dr Frida Ponthan
Dr Alex Elder
et al.
Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression2013
Professor Olaf Heidenreich
Professor Hermann Josef Vormoor
The MLL recombinome of acute leukemias in 20132013
Dr Lindsay Nicholson
Elizabeth Matheson
Lynne Minto
Marian Case
Maryna Sanichar
et al.
Casitas B lymphoma mutations in childhood acute lymphoblastic leukemia2012
Professor Hermann Josef Vormoor
Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group report2012
Dr Alex Elder
Professor Olaf Heidenreich
Professor Hermann Josef Vormoor
Lentiviralmarking as a tool to investigate the clonal complexity and evolution of ALL2012
Professor Hermann Josef Vormoor
Leukaemia & cancer in neonates2012
Professor Hermann Josef Vormoor
The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study2012
Dr Klaus Rehe
Professor Olaf Heidenreich
Professor Hermann Josef Vormoor
Beth Gibson
Central Nervous System Involvement in a Xenograft Model of Pre-B Acute Lymphoblastic Leukaemia Is Associated with Dysfunctional CXCR4 Expression and Upregulation of the Neurotropic Chemokine Receptors CCR6 and CX3CR12011
Dr Klaus Rehe
Kerrie Wilson
Dr Simon Bomken
Professor Olaf Heidenreich
Professor Hermann Josef Vormoor
et al.
In acute lymphoblastic leukaemia stemness is frequent and ubiquitous2011
Dr Simon Bomken
Dr Lars Buechler
Dr Klaus Rehe
Dr Frida Ponthan
Dr Helen Blair
et al.
Lentiviral Transduction of Patient Derived Leukaemic Blasts Allowing In Vivo Bioluminescent Monitoring in An NSG Model of Leukaemia Stem Cell Maintenance2011
Dr Frida Ponthan
Hesta McNeill
Dr Lars Buechler
Professor Hermann Josef Vormoor
Professor Olaf Heidenreich
et al.
Significance of Fusion Genes for Maintenance of Leukaemia2011
Patricia Garrido Castro
Dr Simon Bomken
Elda Latif
Michael Batey
Hesta McNeill
et al.
ANGIOPOIETIN1 a Novel Factor Implicated In MLL Rearranged Acute Lymphoblastic Leukemia and Regulated In a Fusion Gene Dependent Manner2010
Patricia Garrido Castro
Dr Simon Bomken
Professor Hermann Josef Vormoor
Professor Olaf Heidenreich
ANGIOPOIETIN-1 expression is modulated by leukaemic fusion genes2010
Elda Latif
Michael Batey
Hesta McNeill
Professor Hermann Josef Vormoor
Professor Olaf Heidenreich
et al.
ANGIOPOIETIN1-a Novel Factor Implicated In MLL-Rearranged Acute Lymphoblastic Leukemia and Regulated In a Fusion Gene-Dependent Manner2010
Professor Hermann Josef Vormoor
Cytotoxic T cells transduced with chimeric anti-CD19 receptors prevent engraftment of primary lymphoblastic leukemia in vivo2010
Henrike Knizia
Michael Batey
Gilberto de Almeida
Dr Ross Maxwell
Dr Petra Dildey
et al.
Development of an orthotopic model for human malignant bone diseases in immunocompromised NOD.Cg-PrkdcscidIl2rgtmlwjl/szj (NSG) mice2010
Dr Klaus Rehe
Kerrie Wilson
Dr Simon Bomken
Hesta McNeill
Professor Julie Irving
et al.
In Acute Lymphoblastic Leukaemia, Stemness Is Frequent and Ubiquitous2010
Dr Klaus Rehe
Kerrie Wilson
Dr Simon Bomken
Hesta McNeill
Professor Julie Irving
et al.
In Acute Lymphoblastic Leukaemia, Sternness Is Frequent and Ubiquitous2010
Dr Klaus Rehe
Kerrie Wilson
Dr Simon Bomken
Hesta McNeill
Professor Julie Irving
et al.
In acute lymphoblastic leukemia, stemness is frequent and ubiquitous2010
Dr Klaus Rehe
Kerrie Wilson
Hesta McNeill
Professor Julie Irving
Professor Hermann Josef Vormoor
et al.
In standard and high risk acute lymphoblastic leukemias disease propagating cells are abundant and not confined to certain immunophenotypic fractions2010
Dr Andreas Gessner
Patricia Garrido Castro
Dr Anja Scholz
Professor Hermann Josef Vormoor
Professor Olaf Heidenreich
et al.
Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT2010
Dr Simon Bomken
Dr Svetlana Mysina
Professor Olaf Heidenreich
Professor Hermann Josef Vormoor
The Germline Stem Cell Self-Renewal Gene PIWIL2 is Expressed in Both Malignant and Non-Malignant Lymphoid Cells2010
Dr Simon Bomken
Professor Hermann Josef Vormoor
Professor Olaf Heidenreich
The Prosurvival Cytokine Angiopoietin-1 is Overexpressed in T(4;11)-Positive ALL and Regulated in a MLL/AF4 Dependent Manner2010
Dr Simon Bomken
Dr Karel Fiser
Professor Olaf Heidenreich
Professor Hermann Josef Vormoor
Understanding the cancer stem cell2010
Professor Hermann Josef Vormoor
A new subgroup of high-risk acute lymphoblastic leukaemia2009
Patricia Garrido Castro
Dr Andreas Gessner
Joachim Greiling
Professor Hermann Josef Vormoor
Professor Olaf Heidenreich
et al.
Caspase inhibition blocks apoptosis caused by MLL-AF4 depletion in t(4;11) positive ALL cell lines, but cannot abrogate subsequent necroptosis-like cell death2009
Dr Andreas Gessner
Professor Olaf Heidenreich
Professor Hermann Josef Vormoor
Caspase inhibition blocks apoptosis caused by MLL-AF4 depletion in t(4;11)-positive ALL cell lines, but cannot abrogate subsequent necroptosis-like cell death2009
Professor Hermann Josef Vormoor
CD19-Redirected Cytotoxic T Cells Prevent Engraftment of Primary Human Leukemia Cells In Vivo2009
Dr Simon Bomken
Professor Hermann Josef Vormoor
Childhood leukaemia2009
Dr Klaus Rehe
Kerrie Wilson
Hesta McNeill
Professor Hermann Josef Vormoor
Disease Propagating Blasts in Standard and High Risk Acute Lymphoblastic Leukemia Are Frequent and of Diverse Immunophenotype2009
Kate Wilson
Marian Case
Lynne Minto
Professor Simon Bailey
Dr Nicholas Bown
et al.
Flow minimal residue disease monitoring of candidate leukemic stem cells defined by the immunophenotype, CD34+CD38lowCD19+ in B-lineage childhoood acute lymphoblastic leukemia2009
Professor Hermann Josef Vormoor
Malignant stem cells in childhood acute lymphoblastic leukemia: The stem cell concept revisited2009
Professor Olaf Heidenreich
Professor Hermann Josef Vormoor
Malignant stem cells in childhood ALL: the debate continues!2009
Richard Feltbower
Dr Richard McNally
Professor Stephen Proctor
Professor Roderick Skinner
Professor Hermann Josef Vormoor
et al.
The epidemiology of leukaemia and lymphoma in children and young adults from the north of England, 1990-20022009
Professor Hermann Josef Vormoor
Adjuvant therapy with small hairpin RNA interference prevents non-small cell lung cancer metastasis development in mice2008
Dr Simon Bomken
Kerrie Wilson
Professor Julie Irving
Professor Hermann Josef Vormoor
In Childhood Acute Lymphoblastic Leukemia, Blasts at Different Stages of Immunophenotypic Maturation Have Stem Cell Properties2008
Kerrie Wilson
Dr Klaus Rehe
Dr Simon Bomken
Marian Case
Professor Julie Irving
et al.
In Childhood ALL, Both Blasts with a CD20(-/Low) and a CD20(High) Immunophenotype, Have the Ability to Transfer the Leukemia Onto Immune-Deficient NOD/Scid Y-/- Mice2008
Professor Hermann Josef Vormoor
Long term follow-up in three pediatric patients with Farber Disease, Type 2/3, following allogeneic hematopoietic stem cell transplantation from related and unrelated donors2008
Dr Karel Fiser
Professor Julie Irving
Professor Hermann Josef Vormoor
MRD Monitoring of Childhood ALL Using Hierarchical Clustering and Support Vector Machine Learning of Complex Multi-Parameter Flow Cytometry Data2008
Marian Case
Elizabeth Matheson
Lynne Minto
Dr Nicholas Bown
Professor Simon Bailey
et al.
Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia2008
Professor Hermann Josef Vormoor
Secondary antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell recipients2008
Marian Case
Elizabeth Matheson
Lynne Minto
Professor Christine Harrison FRCPath FMedSci
Dr Nicholas Bown
et al.
Somatic mutation of genes impacting on the RAS-RAF-MEK-ERK pathway is the most common genetic abnormality in childhood acute lymphoblastic leukaemia, is implicated in disease progression and provides a rationale for therapeutic targeting2008
Kerrie Wilson
Marian Case
Lynne Minto
Professor Simon Bailey
Professor Hermann Josef Vormoor
et al.
The CD34+ CD38Low CD19+ Candidate Leukemic Stem Cell Phenotype Revisited: Useful for Flow MRD Monitoring?2008
Professor Hermann Josef Vormoor
Characterisation of candidate malignant stem cell populations in childhood B-cell precusor acute lymphoblastic leukaemia2007
Professor Hermann Josef Vormoor
Characterisation of the stem cell compartment in childhood ALL2007
Professor Hermann Josef Vormoor
Cytotoxicity of dimethylacetamide and pharmacokinetics in children receiving intravenous busulfan2007
Professor Hermann Josef Vormoor
Farber disease: Clinical presentation, pathogenesis and a new approach to treatment2007
Dr Karel Fiser
Professor Hermann Josef Vormoor
Identifying candidate normal and leukemic B cell progenitor populations with hierarchical clustering of 6-color flow cytometry data - A better view2007
Henrike Knizia
Professor Hermann Josef Vormoor
Identifying cellular mechanisms of organ-specific metastasis of Ewing tumours2007
Professor Hermann Josef Vormoor
Identifying the acute lymphoblastic leukemia stem cell2007
Professor Hermann Josef Vormoor
Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemia2007
Professor Hermann Josef Vormoor
Bordetella pertussis respiratory infection following hematopoietic stem cell transplantation: time for universal vaccination?2006
Professor Hermann Josef Vormoor
CD28 co-stimulation via tumour-specific chimaeric receptors induces an incomplete activation response in Epstein-Barr virus-specific effector memory T cells2006
Professor Hermann Josef Vormoor
CD34+CD19-, CD34+CD19+ and CD34-CD19+ cells may all have leukemia-initiating potential in NOD/Scid mice2006
Professor Hermann Josef Vormoor
Farber's disease without central nervous system involvement: Bone-marrow transplantation provides a promising new approach [1]2006
Professor Hermann Josef Vormoor
Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system–negative stage III or IV lymphoblastic lymphoma2006
Professor Hermann Josef Vormoor
Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11)2006
Professor Hermann Josef Vormoor
No improvement of overall-survival in children with high-risk acute myeloid leukemia by stem cell transplantation in 1st complete remission2006
Professor Hermann Josef Vormoor
Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome2006
Professor Hermann Josef Vormoor
PET/CT with diagnostic CT in the evaluation of childhood sarcoma2006
Professor Hermann Josef Vormoor
Successful high-resolution animal positron emission tomography of human Ewing tumours and their metastases in a murine xenograft model2006
Professor Hermann Josef Vormoor
Target antigen expression on a professional antigen-presenting cell induces superior proliferative antitumor T-cell responses via chimeric T-cell receptors2006
Professor Hermann Josef Vormoor
Treatment of refractory CMV-infection following hematopoietic stem cell transplantation with the combination of foscarnet and leflunomide2006
Professor Hermann Josef Vormoor
Whole-Body PET/CT with 11C-Meta-Hydroxyephedrine in tumors of the sympathetic nervous system: Feasibility study and comparison with 123I-MIBG SPECT/CT2006
Professor Hermann Josef Vormoor
Adoptive cellular immunotherapy with CD19-specific T cells2005
Professor Hermann Josef Vormoor
Agressive fibromatosis involving the mandible: Case report and review of the literature2005
Professor Hermann Josef Vormoor
Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre-emptive immunotherapy2005
Professor Hermann Josef Vormoor
Duration of storage of autologous hematopoietic stem cell products for children and adolescents with malignant diseases2005
Professor Hermann Josef Vormoor
Heterogeneity of radiation induced apoptosis in Ewing Tumor cell lines characterized on a single cell level2005
Professor Hermann Josef Vormoor
Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning2005
Professor Hermann Josef Vormoor
Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells2005
Professor Hermann Josef Vormoor
Metastatic neuroblastoma demonstrated by whole-body PET-CT using 11C-HED2005
Professor Hermann Josef Vormoor
PI3K/AKT is involved in mediating survival signals that rescue Ewing tumour cells from fibroblast growth factor 2-induced cell death2005
Professor Hermann Josef Vormoor
Toxicity and pharmacokinetics of i.v. busulfan in children before stem cell transplantation2005
Professor Hermann Josef Vormoor
Changed adhesion molecule profile of Ewing tumor cell lines and xenografts under the influence of ionizing radiation2004
Professor Hermann Josef Vormoor
Factors affecting the efficacy of peripheral blood progenitor cells collections by large-volume leukaphereses with standardized processing volumes2004
Professor Hermann Josef Vormoor
Haematopoetic stem cell transplantation for refractory autoimmune cytopenia2004
Professor Hermann Josef Vormoor
Human gammadelta T cells as mediators of chimaeric-receptor redirected anti-tumour immunity2004
Professor Hermann Josef Vormoor
Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective2004
Professor Hermann Josef Vormoor
Pharmacokinetic interaction between voriconazole and ciclosporin A following allogeneic bone marrow transplantation2004
Professor Hermann Josef Vormoor
Successful hematopoietic stem cell transplantation in Farber disease2004
Professor Hermann Josef Vormoor
Unique SDF-1–induced activation of human precursor-BALL cells as a result of altered CXCR4 expression and signaling2004
Professor Hermann Josef Vormoor
Durable clearance of hepatitis B virus after allogeneic blood stem cell transplantation by adoptive immunity transfer and antiviral chemotherapy2003
Professor Hermann Josef Vormoor
Effect of radiation on Ewing tumour subpopulations characterized on a single-cell level: intracellular cytokine, immunophenotypic, DNA and apoptotic profile2003
Professor Hermann Josef Vormoor
Identification of two distinct subpopulations in a ganglioneuroblastoma: lack of co-localization of vasoactive intestinal polypeptide and calcitonin in ganglionic cells at the ultrastructural level2003
Professor Hermann Josef Vormoor
Osteosarcoma after allogeneic bone marrow transplantation: A report of four cases from the Cooperative Osteosarcoma Study Group (COSS)2003
Professor Hermann Josef Vormoor
Time- and dose-dependent changes of intracellular cytokine and cytokine receptor profile of Ewing tumour subpopulations under the influence of ionizing radiation2003
Professor Hermann Josef Vormoor
Binding of two nuclear complexes to a novel regulatory element within the human S100A9 promoter drives the S100A9 gene expression2002
Professor Hermann Josef Vormoor
c-KIT-expressing Ewing tumour cells are insensitive to imatinib mesylate (STI571)2002
Professor Hermann Josef Vormoor
Current state of cord blood transplantation in childhood2002
Professor Hermann Josef Vormoor
Immature CD34+CD19- progenitor/stem cells in TEL/AML1-positive acute lymphoblastic leukemia are genetically and functionally normal2002
Professor Hermann Josef Vormoor
Minimal residual disease in acute myeloid leukemia in children--standardization and evaluation of immunophenotyping in the AML-BFM-98 study2002
Professor Hermann Josef Vormoor
Targeting CD19 with genetically modified EBV-specific human T lymphocytes2002
Professor Hermann Josef Vormoor
Autologous peripheral blood stem cell transplantation and anti-B-cell directed immunotherapy for refractory auto-immune haemolytic anaemia2001
Professor Hermann Josef Vormoor
Establishment of an in vivo model for pediatric Ewing tumors by transplantation into NOD/scid mice2001
Professor Hermann Josef Vormoor
Cell heterogeneity and subpopulations in solid tumors characterized by simultaneous immunophenotyping and DNA content analysis2000
Professor Hermann Josef Vormoor
Expression of AC133 and CD117 on candidate normal stem cell populations in childhood B-cell precursor acute lymphoblastic leukaemia1999
Professor Hermann Josef Vormoor
Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism1999
Professor Hermann Josef Vormoor
Flow cytometric identification of candidate normal stem cell populations in CD45-negative B-cell precursor acute lymphoblastic leukaemia1998
Professor Hermann Josef Vormoor
Good engraftment of B-cell precursor ALL in NOD-SCID mice1997
Professor Hermann Josef Vormoor
Flow cytometric characterization of differentiation events and primitive stem cell populations in childhood B-cell precursor ALL1996
Professor Hermann Josef Vormoor
Identification of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice1996
Professor Hermann Josef Vormoor
Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy1996
Professor Hermann Josef Vormoor
Myelodysplasia and acute myelogenous leukemia in Down's syndrome: A report of 40 children of the AML-BFM Study Group1996
Professor Hermann Josef Vormoor
Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis1996
Professor Hermann Josef Vormoor
Therapy of childhood acute myelogenous leukemias1996
Professor Hermann Josef Vormoor
Engraftment of immune-deficient mice with primitive hematopoietic cells from beta-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocols1995
Professor Hermann Josef Vormoor
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice1994
Professor Hermann Josef Vormoor
Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice1994
Dr Andrew Hall
Professor Hermann Josef Vormoor
Increased DNA-repair capacity and the modulation of 2 proteins in and metallothionein overexpressing Chinese hamster cell line1994
Professor Hermann Josef Vormoor
SCID mice as an in vivo model of human cord blood hematopoiesis1994
Professor Hermann Josef Vormoor
High-level multilineage engraftment of human cord blood cells in SCID mice1993
Professor Hermann Josef Vormoor
Acute myelogenous leukaemia in children under 2 years: Experiences of the West German AML studies BFM-78, -83 and -871992
Professor Hermann Josef Vormoor
Transient myeloproliferative disorders and acute myelogenous leukemia in infants with Down's syndrome1990
Professor Hermann Josef Vormoor
Incidence and prognostic significance of Auer rods in children with acute myeloid leukemia in the studies AML-BFM-78 and -831989
Professor Hermann Josef Vormoor
Prognostic significance of Auer rods in childhood acute myelogenous leukemia: results of the studies AML-BFM-78 and -831989